The Lablite project: A cross-sectional mapping survey of decentralized HIV service provision in Malawi, Uganda and Zimbabwe

Table 6 CD4 tests performed per month in health facilities providing ART on-site with data available

	Malawi			Uganda			Zimbabwe
	Primary	Secondary	Tertiary	Primary	Secondary	Tertiary	Primary	Secondary
All facilities	(n = 2)	(n = 1)	(n = 1)	(n = 4)	(n = 14^$)	(n = 1)	(n = 7)	(n = 6)
CD4s per month	84 (77–91)	57	831	40 (27–141)	82 (19–152)	388	10 (6–30)	171 (12–312)
Adults* on ART	201; missing	9,600	17,453	189 (74–705)	576 (336–874)	2,412	263 (129–1,845)	2,800 (1,976-3,726)
Adults initiating ART per month	46 (40–52)	478	597	11 (7–22)	27 (12–34)	35	13 (6–20)	50 (40–100)
Facilities where adults initiating ART per month <5% total adults* on ART	(n = 0)	(n = 1)	(n = 1)	(n = 2)	(n = 9^$$)	(n = 1)	(n = 4)	(n = 5)
Estimated frequency of CD4s in adults* on ART**
At least 6-monthly		0	0	2	2	0	0	0
Every 6 months to 1 year		0	0	0	2	1	0	1
Every 1 to 2 years		0	1	0	2	0	1	1
Less than once every 2 years		1	0	0	3	0	3	3

Values are median (IQR) or n.
Sample collection and testing was on-site at all facilities in Malawi, tertiary care facilities in Uganda and secondary care facilities in Zimbabwe. Samples were taken on-site and sent to a referral laboratory at all primary care facilities in Uganda and Zimbabwe.
^$Sample collection and testing on-site (n = 7), samples taken on-site and sent to a referral laboratory (n = 6), patients sent to a referral laboratory (n = 1).
^$$Sample collection and testing on-site (n = 4), samples taken on-site and sent to a referral laboratory (n = 4), patients sent to a referral laboratory (n = 1).
*Current adult patients at facility (except for Malawi where numbers are all ART patients).
**Estimated assuming constant number of patients on ART and constant rate of CD4-testing (includes all CD4s although some will be for initiation or in children). Of these facilities 0/1, 0/1 facilities in Malawi, 2/2, 6/9, 1/1 facilities in Uganda and 2/4, 2/5 facilities in Zimbabwe reported CD4-monitoring in adults was at least 6-monthly (across non-empty cells).

ISSN: 1472-6963